96 related articles for article (PubMed ID: 22841978)
1. Myriocin, an inhibitor of serine palmitoyl transferase, impairs the uptake of transferrin and low-density lipoprotein in mammalian cells.
Meyer SG; Wendt AE; Scherer M; Liebisch G; Kerkweg U; Schmitz G; de Groot H
Arch Biochem Biophys; 2012 Oct; 526(1):60-8. PubMed ID: 22841978
[TBL] [Abstract][Full Text] [Related]
2. Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes.
Castro EV; Yoneyama KG; Haapalainen EF; Toledo MS; Takahashi HK; Straus AH
J Eukaryot Microbiol; 2013; 60(4):377-87. PubMed ID: 23659342
[TBL] [Abstract][Full Text] [Related]
3. The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.
Ciesek S; Steinmann E; Manns MP; Wedemeyer H; Pietschmann T
J Infect Dis; 2008 Oct; 198(7):1091-3. PubMed ID: 18774886
[No Abstract] [Full Text] [Related]
4. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.
Miyake Y; Kozutsumi Y; Nakamura S; Fujita T; Kawasaki T
Biochem Biophys Res Commun; 1995 Jun; 211(2):396-403. PubMed ID: 7794249
[TBL] [Abstract][Full Text] [Related]
5. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
6. Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis.
Lee YS; Choi KM; Lee S; Sin DM; Lim Y; Lee YM; Hong JT; Yun YP; Yoo HS
Cancer Biol Ther; 2012 Jan; 13(2):92-100. PubMed ID: 22336910
[TBL] [Abstract][Full Text] [Related]
7. Myriocin, a serine palmitoyltransferase inhibitor, increases melanin synthesis in Mel-Ab cells and a skin equivalent model.
Li H; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Pharmazie; 2014 Mar; 69(3):187-91. PubMed ID: 24716407
[TBL] [Abstract][Full Text] [Related]
8. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
9. The essential structures of ISP-I that influence serine palmitoyltransferase inhibition in Chinese hamster ovary cells.
Mizukoshi K; Matsumoto K; Hirose R; Fujita T
Biol Pharm Bull; 2012; 35(8):1349-53. PubMed ID: 22863936
[TBL] [Abstract][Full Text] [Related]
10. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
[TBL] [Abstract][Full Text] [Related]
11. Fungal metabolite sulfamisterin suppresses sphingolipid synthesis through inhibition of serine palmitoyltransferase.
Yamaji-Hasegawa A; Takahashi A; Tetsuka Y; Senoh Y; Kobayashi T
Biochemistry; 2005 Jan; 44(1):268-77. PubMed ID: 15628868
[TBL] [Abstract][Full Text] [Related]
12. A novel role for sphingolipid intermediates in activation-induced cell death in T cells.
Solomon JC; Sharma K; Wei LX; Fujita T; Shi YF
Cell Death Differ; 2003 Feb; 10(2):193-202. PubMed ID: 12700647
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.
Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye KA; Stocker R; Jessup W; Garner B
Biochem Pharmacol; 2007 May; 73(9):1340-6. PubMed ID: 17239824
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation.
Bhat VK; Bernhart E; Plastira I; Fan K; Ghaffari-Tabrizi-Wizsy N; Wadsack C; Rechberger G; Eichmann T; Asslaber M; Spassova I; Verhaegen ME; Malle E; Becker JC; Sattler W
J Invest Dermatol; 2019 Apr; 139(4):807-817. PubMed ID: 30399362
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipid synthesis is involved in autophagy in Saccharomyces cerevisiae.
Yamagata M; Obara K; Kihara A
Biochem Biophys Res Commun; 2011 Jul; 410(4):786-91. PubMed ID: 21703229
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
17. Determination of the serine palmitoyl transferase inhibitor myriocin by electrospray and Q-trap mass spectrometry.
Campisi GM; Signorelli P; Rizzo J; Ghilardi C; Antognetti J; Caretti A; Lazarević JS; Strettoi E; Novelli E; Ghidoni R; Rubino FM; Paroni R
Biomed Chromatogr; 2017 Dec; 31(12):. PubMed ID: 28621883
[TBL] [Abstract][Full Text] [Related]
18. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest.
Lee YS; Choi KM; Choi MH; Ji SY; Lee S; Sin DM; Oh KW; Lee YM; Hong JT; Yun YP; Yoo HS
Cell Prolif; 2011 Aug; 44(4):320-9. PubMed ID: 21645154
[TBL] [Abstract][Full Text] [Related]
19. Sphingoid base synthesis requirement for endocytosis in Saccharomyces cerevisiae.
Zanolari B; Friant S; Funato K; Sütterlin C; Stevenson BJ; Riezman H
EMBO J; 2000 Jun; 19(12):2824-33. PubMed ID: 10856228
[TBL] [Abstract][Full Text] [Related]
20. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
